Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Wounds and Injuries | 6 | 2019 | 334 | 1.260 |
Why?
|
Wounds, Penetrating | 2 | 2021 | 45 | 0.830 |
Why?
|
Zygomycosis | 1 | 2018 | 3 | 0.650 |
Why?
|
Fasciitis, Necrotizing | 1 | 2018 | 15 | 0.640 |
Why?
|
Hepatitis C | 1 | 2018 | 114 | 0.590 |
Why?
|
Referral and Consultation | 1 | 2018 | 383 | 0.540 |
Why?
|
Trauma Centers | 8 | 2021 | 197 | 0.520 |
Why?
|
Emergency Treatment | 1 | 2014 | 52 | 0.480 |
Why?
|
Surgical Procedures, Operative | 1 | 2014 | 124 | 0.460 |
Why?
|
Mass Screening | 1 | 2018 | 838 | 0.420 |
Why?
|
Critical Care | 1 | 2014 | 263 | 0.410 |
Why?
|
HIV Infections | 1 | 2018 | 775 | 0.370 |
Why?
|
Rib Fractures | 2 | 2021 | 37 | 0.370 |
Why?
|
Wounds, Nonpenetrating | 3 | 2021 | 131 | 0.360 |
Why?
|
Iatrogenic Disease | 1 | 2009 | 36 | 0.340 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2009 | 64 | 0.330 |
Why?
|
Granuloma, Plasma Cell | 1 | 2008 | 8 | 0.330 |
Why?
|
Esophageal Stenosis | 1 | 2008 | 36 | 0.320 |
Why?
|
Workload | 1 | 2009 | 103 | 0.320 |
Why?
|
Esophageal Diseases | 1 | 2008 | 95 | 0.320 |
Why?
|
Postoperative Complications | 2 | 2021 | 1615 | 0.310 |
Why?
|
Pelvic Bones | 2 | 2017 | 7 | 0.290 |
Why?
|
Fractures, Bone | 2 | 2017 | 132 | 0.260 |
Why?
|
Fibromatosis, Aggressive | 1 | 2005 | 5 | 0.250 |
Why?
|
Thoracic Neoplasms | 1 | 2005 | 10 | 0.250 |
Why?
|
Thoracic Wall | 1 | 2005 | 20 | 0.250 |
Why?
|
Retrospective Studies | 12 | 2021 | 7268 | 0.240 |
Why?
|
Hemorrhage | 2 | 2017 | 328 | 0.240 |
Why?
|
Adult | 15 | 2021 | 21379 | 0.230 |
Why?
|
Internship and Residency | 1 | 2009 | 596 | 0.230 |
Why?
|
Humans | 25 | 2021 | 68549 | 0.200 |
Why?
|
Accidental Falls | 2 | 2019 | 84 | 0.200 |
Why?
|
Male | 17 | 2021 | 37283 | 0.190 |
Why?
|
Drainage | 1 | 2021 | 133 | 0.190 |
Why?
|
Methocarbamol | 1 | 2020 | 3 | 0.190 |
Why?
|
Resuscitation | 2 | 2019 | 77 | 0.190 |
Why?
|
Pancreatectomy | 1 | 2021 | 129 | 0.190 |
Why?
|
Accidents, Traffic | 1 | 2021 | 109 | 0.180 |
Why?
|
Pancreas | 1 | 2021 | 225 | 0.180 |
Why?
|
Hypoventilation | 1 | 2019 | 8 | 0.180 |
Why?
|
Female | 19 | 2021 | 38021 | 0.170 |
Why?
|
Shock, Hemorrhagic | 1 | 2019 | 33 | 0.170 |
Why?
|
Factor Xa Inhibitors | 1 | 2019 | 43 | 0.170 |
Why?
|
Carbon Dioxide | 1 | 2019 | 78 | 0.170 |
Why?
|
Middle Aged | 14 | 2021 | 21119 | 0.170 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 80 | 0.170 |
Why?
|
Mobile Applications | 1 | 2021 | 138 | 0.170 |
Why?
|
Mastectomy | 3 | 2009 | 56 | 0.160 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 51 | 0.160 |
Why?
|
Early Diagnosis | 1 | 2018 | 122 | 0.160 |
Why?
|
Breast Neoplasms | 4 | 2009 | 1533 | 0.160 |
Why?
|
Splenic Artery | 1 | 2017 | 16 | 0.150 |
Why?
|
Splenectomy | 1 | 2017 | 40 | 0.150 |
Why?
|
Antifungal Agents | 1 | 2018 | 108 | 0.150 |
Why?
|
Vascular System Injuries | 1 | 2017 | 20 | 0.150 |
Why?
|
Embolization, Therapeutic | 2 | 2017 | 150 | 0.150 |
Why?
|
Abdominal Injuries | 1 | 2017 | 60 | 0.150 |
Why?
|
Aneurysm, False | 1 | 2017 | 60 | 0.150 |
Why?
|
Spleen | 1 | 2017 | 301 | 0.140 |
Why?
|
Stomach Ulcer | 1 | 2016 | 14 | 0.140 |
Why?
|
Traumatology | 1 | 2015 | 20 | 0.130 |
Why?
|
Patient Education as Topic | 1 | 2018 | 424 | 0.130 |
Why?
|
Time Factors | 3 | 2019 | 4655 | 0.130 |
Why?
|
Awareness | 1 | 2015 | 81 | 0.130 |
Why?
|
Enteral Nutrition | 1 | 2016 | 157 | 0.130 |
Why?
|
Critical Illness | 1 | 2016 | 191 | 0.130 |
Why?
|
Career Choice | 1 | 2015 | 98 | 0.120 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2016 | 185 | 0.120 |
Why?
|
Injury Severity Score | 3 | 2021 | 204 | 0.120 |
Why?
|
Unconsciousness | 1 | 2013 | 6 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 1140 | 0.110 |
Why?
|
Students, Medical | 1 | 2015 | 210 | 0.110 |
Why?
|
Shock | 1 | 2013 | 28 | 0.110 |
Why?
|
Trauma Severity Indices | 1 | 2013 | 80 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2016 | 384 | 0.100 |
Why?
|
Prospective Studies | 5 | 2019 | 3703 | 0.100 |
Why?
|
Aged | 7 | 2019 | 14842 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2017 | 3256 | 0.100 |
Why?
|
Young Adult | 5 | 2021 | 5710 | 0.090 |
Why?
|
Incidence | 3 | 2021 | 1582 | 0.090 |
Why?
|
Stress, Psychological | 1 | 2016 | 824 | 0.090 |
Why?
|
Databases, Factual | 1 | 2013 | 621 | 0.090 |
Why?
|
Registries | 1 | 2013 | 730 | 0.090 |
Why?
|
Salaries and Fringe Benefits | 1 | 2009 | 29 | 0.090 |
Why?
|
Stilbenes | 1 | 2009 | 57 | 0.080 |
Why?
|
Caspases | 1 | 2009 | 194 | 0.080 |
Why?
|
Esophagectomy | 1 | 2008 | 26 | 0.080 |
Why?
|
Rare Diseases | 1 | 2008 | 41 | 0.080 |
Why?
|
Anastomosis, Surgical | 1 | 2008 | 104 | 0.080 |
Why?
|
Suicide | 1 | 2009 | 115 | 0.080 |
Why?
|
Syndrome | 1 | 2008 | 255 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 177 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2008 | 150 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 2324 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2008 | 136 | 0.070 |
Why?
|
Albuminuria | 1 | 2008 | 171 | 0.070 |
Why?
|
Statistics, Nonparametric | 2 | 2019 | 306 | 0.070 |
Why?
|
Cohort Studies | 2 | 2009 | 2356 | 0.070 |
Why?
|
Burns | 1 | 2008 | 83 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2008 | 1851 | 0.070 |
Why?
|
Inflammation | 2 | 2008 | 1030 | 0.060 |
Why?
|
Practice Patterns, Physicians' | 1 | 2009 | 503 | 0.060 |
Why?
|
Mitochondria | 1 | 2009 | 643 | 0.060 |
Why?
|
Biopsy, Needle | 1 | 2005 | 191 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2016 | 7028 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 1860 | 0.060 |
Why?
|
Risk Factors | 3 | 2021 | 5720 | 0.050 |
Why?
|
Ultrasonography | 1 | 2005 | 453 | 0.050 |
Why?
|
Apoptosis | 1 | 2009 | 1641 | 0.050 |
Why?
|
Risk Assessment | 1 | 2008 | 2004 | 0.050 |
Why?
|
Mammography | 1 | 2005 | 310 | 0.050 |
Why?
|
Conservative Treatment | 1 | 2021 | 8 | 0.050 |
Why?
|
Pilot Projects | 2 | 2021 | 1341 | 0.050 |
Why?
|
United States | 2 | 2016 | 7338 | 0.050 |
Why?
|
Ribs | 1 | 2021 | 25 | 0.050 |
Why?
|
Motor Vehicles | 1 | 2021 | 20 | 0.050 |
Why?
|
Smartphone | 1 | 2021 | 69 | 0.050 |
Why?
|
Tidal Volume | 1 | 2019 | 17 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 2019 | 41 | 0.040 |
Why?
|
Plasma | 1 | 2019 | 58 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2021 | 230 | 0.040 |
Why?
|
Exsanguination | 1 | 2019 | 8 | 0.040 |
Why?
|
Geriatrics | 1 | 2019 | 69 | 0.040 |
Why?
|
Vermont | 2 | 2009 | 21 | 0.040 |
Why?
|
Wounds, Gunshot | 1 | 2019 | 48 | 0.040 |
Why?
|
Pain Management | 1 | 2020 | 186 | 0.040 |
Why?
|
Communication | 1 | 2021 | 329 | 0.040 |
Why?
|
Reference Values | 1 | 2019 | 579 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 219 | 0.040 |
Why?
|
Cause of Death | 1 | 2019 | 241 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 536 | 0.040 |
Why?
|
Multiple Trauma | 1 | 2017 | 50 | 0.040 |
Why?
|
Brain Injuries, Traumatic | 1 | 2019 | 105 | 0.040 |
Why?
|
Hemostatic Techniques | 1 | 2017 | 23 | 0.040 |
Why?
|
Length of Stay | 1 | 2020 | 780 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 772 | 0.040 |
Why?
|
Histamine H2 Antagonists | 1 | 2016 | 45 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2019 | 225 | 0.030 |
Why?
|
Fracture Fixation | 1 | 2016 | 32 | 0.030 |
Why?
|
Marketing of Health Services | 1 | 2015 | 18 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2017 | 205 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 1465 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 4843 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2016 | 190 | 0.030 |
Why?
|
Pregnancy | 1 | 2021 | 2334 | 0.030 |
Why?
|
Sex Factors | 1 | 2019 | 1265 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 498 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2015 | 88 | 0.030 |
Why?
|
Adolescent | 3 | 2016 | 8904 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2016 | 344 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 148 | 0.030 |
Why?
|
Survival Rate | 1 | 2016 | 1055 | 0.030 |
Why?
|
Triage | 1 | 2013 | 109 | 0.030 |
Why?
|
Pterocarpus | 1 | 2009 | 1 | 0.020 |
Why?
|
Caspase Inhibitors | 1 | 2009 | 36 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2009 | 85 | 0.020 |
Why?
|
Superoxides | 1 | 2009 | 70 | 0.020 |
Why?
|
Carcinoma, Ductal | 1 | 2009 | 14 | 0.020 |
Why?
|
Self-Injurious Behavior | 1 | 2009 | 31 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 2265 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2009 | 45 | 0.020 |
Why?
|
Fruit | 1 | 2009 | 86 | 0.020 |
Why?
|
Social Class | 1 | 2009 | 127 | 0.020 |
Why?
|
South Carolina | 1 | 2015 | 2752 | 0.020 |
Why?
|
Contraindications | 1 | 2008 | 52 | 0.020 |
Why?
|
Cell Division | 1 | 2009 | 541 | 0.020 |
Why?
|
Plant Extracts | 1 | 2009 | 122 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2009 | 489 | 0.020 |
Why?
|
Mastectomy, Segmental | 1 | 2008 | 63 | 0.020 |
Why?
|
Cell Cycle | 1 | 2009 | 312 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 546 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 369 | 0.020 |
Why?
|
Albumins | 1 | 2008 | 72 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2008 | 59 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2015 | 2798 | 0.020 |
Why?
|
Creatinine | 1 | 2008 | 243 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2009 | 652 | 0.020 |
Why?
|
Up-Regulation | 1 | 2009 | 682 | 0.020 |
Why?
|
Cell Survival | 1 | 2009 | 901 | 0.020 |
Why?
|
Acute Disease | 1 | 2008 | 658 | 0.020 |
Why?
|
Rural Population | 1 | 2009 | 397 | 0.020 |
Why?
|
Decision Making | 1 | 2008 | 410 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 1851 | 0.020 |
Why?
|
Hospitalization | 1 | 2009 | 977 | 0.010 |
Why?
|